Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 27 tumour microenvironment PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


tumour microenvironment PhD Projects, Programmes & Scholarships

We have 27 tumour microenvironment PhD Projects, Programmes & Scholarships

Cancer cells ‘feed’ on extracellular matrix components under starvation conditions: how can they do it?

Background. The tumour microenvironment (TME) has a key role in promoting tumour formation and progression. In breast and pancreatic cancers, this accompanied by the accumulation of extracellular matrix (ECM) in the TME. Read more

Postgraduate Research Opportunities at the Faculty of Medicine and Dentistry

To deliver our research strategy of ‘Better Health for All' and our aspiration to train the research leaders of the future, the Faculty of Medicine and Dentistry (top 10% faculties of medicine in the world, QS2022) has opened opportunities for self-funded PhD students in multiple areas of biomedical and translational research across six internationally recognised Research Institutes. Read more

Developing novel therapeutic strategies to better treat Triple Negative Breast Cancer

One in two people will develop cancer in their lifetime and it is a leading cause of death.  While significant progress has been made in the treatment of some cancers, there still remain some forms of the disease with limited treatment options and poor outcome. . Read more

Investigating molecular drivers of cell invasion

The Wells laboratory focusses on exploring the molecular mechanisms that underlie cell invasion. We have interests in cancer cell invasion and hemopoietic cell invasion. Read more

Targeting dormant cancer cells in myeloma

Multiple myeloma is the second most common blood cancer and remains essentially incurable. Chemotherapy is effective at reducing tumour and extends survival, but it never fully eradicates disease, so patients face inevitable relapse. Read more

Filtering Results